In conclusion, both TIG1A and TIG1B suppressed PGE2-stimulated colon cancer cell proliferation, β-catenin nuclear localization, β-catenin/TCF transactivation, and cAMP/CREB signaling through expression of GRK5. This evidence concerns the gene GRK5 and malignant colon neoplasm.